EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors

Marc D Schwartz, Beth N Peshkin, Claudine Isaacs, Christopher Grisham, Nora J Holmes, Lia J Sorgen, Sean Collins, Nancy Dawson, Colleen McGuire, Tobechukwu Okobi, Kelsey Newell, Kavitha A Kolla und 1 weitere

Journal of the National Comprehensive Cancer Network · 2023

DOI: 10.6004/jnccn.2023.7071 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023. Verfasst von Marc D Schwartz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. Hauptthemen laut MEDLINE: Cancer Survivors, Prostatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Germline genetic testing is recommended for men with metastatic or high-risk prostate cancer to inform treatment and risk management for other cancers and inform genetic testing in at-risk relatives. However, relatively few patients with prostate cancer undergo genetic testing. Given the low rate of testing and increasing demands on genetic service providers, strategies are needed that reduce barriers to testing while conserving genetic counseling resources. The primary goal of this study was to determine whether a proactive and streamlined “traceback” approach could yield increased genetic testing participation among prostate cancer survivors.

Methods

We randomized 107 survivors of metastatic and high-risk prostate cancer to streamlined testing (ST) versus enhanced usual care (EUC). ST participants were proactively provided with print genetic education materials and the option to proceed to genetic testing without pre-test genetic counseling. EUC participants were sent a letter from their physician advising them of their eligibility for genetic testing and recommending they schedule genetic counseling. The primary outcome was genetic testing participation. Secondary outcomes were distress, knowledge, decision satisfaction, and regret.

Results

In the ST group, 41.5% of participants completed genetic testing compared with 27.8% in the EUC group. After adjusting for education and marital status, the odds of testing were more than twice as high for the ST group as for the EUC group (odds ratio, 2.57; 95% CI, 1.05–6.29). The groups did not differ on any of the psychosocial outcomes at the 3-month follow-up.

Conclusions

Proactive outreach paired with streamlined genetic testing delivery may be a safe, effective, and resource-efficient approach to facilitate traceback genetic testing in prostate cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsProstatic NeoplasmsHumansMaleGenetic CounselingGenetic TestingMutationPilot ProjectsProstate

Stichwörter der Autor:innen

BRCA1/BRCA2Prostate Cancer SurvivorsTracebackgenetic counselinggenetic testing

Autor:innen und Institutionen

  • Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research, Georgetown University, Washington, DC.
  • University of the District of Columbia, Washington, DC.

Förderung

  • NCI NIH HHS

Zitieren

APA

Schwartz, M. D., Peshkin, B. N., Isaacs, C., Grisham, C., Holmes, N. J., Sorgen, L. J., Collins, S., Dawson, N., McGuire, C., Okobi, T., Newell, K., Kolla, K. A., & Weinstein, V. (2023). Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2023.7071

Vancouver

Schwartz MD, Peshkin BN, Isaacs C, Grisham C, Holmes NJ, Sorgen LJ, et al. Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors. Journal of the National Comprehensive Cancer Network. 2023. doi:10.6004/jnccn.2023.7071

BibTeX
@article{Schwartz2023,
  author = {Schwartz, Marc D and Peshkin, Beth N and Isaacs, Claudine and Grisham, Christopher and Holmes, Nora J and Sorgen, Lia J and Collins, Sean and Dawson, Nancy and McGuire, Colleen and Okobi, Tobechukwu and Newell, Kelsey and Kolla, Kavitha A and Weinstein, Veronique},
  title = {Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2023},
  doi = {10.6004/jnccn.2023.7071}
}
Kostenlos starten →